Novavax trims $50M in costs but did not reduce headcount, CEO says
Covid-19 vaccine manufacturer Novavax cut $50 million worth of expenses in the first quarter of this year but did not lay off any staff, CEO …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.